| Literature DB >> 33244376 |
Giacomo Caio1,2, Lisa Lungaro1, Rosario Cultrera1, Roberto De Giorgio1, Umberto Volta3.
Abstract
The coronavirus disease (Covid-19) has caused a pandemic with more than 600,000 deaths to date. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the beta-coronavirus genus that also includes SARS and the Middle East Respiratory Syndrome Coronavirus (MERS). While the typical presentation is given by respiratory symptoms and fever, some patients also report gastrointestinal symptoms such as diarrhea, nausea, vomiting, and abdominal pain. Several studies have identified the SARS-CoV-2 RNA in stool specimens of infected patients, and its viral receptor angiotensin-converting enzyme 2 (ACE2) is highly expressed in enterocytes. In this short review, we report the frequency of gastrointestinal symptoms in infected patients and suggest possible implications for disease management, transmission, and infection control. ©2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases.Entities:
Keywords: Angiotensin-converting enzyme 2; COVID-19; Diarrhea; Gastrointestinal Presentation; Nausea; SARS-CoV-2; Vomiting.
Year: 2020 PMID: 33244376 PMCID: PMC7682957
Source DB: PubMed Journal: Gastroenterol Hepatol Bed Bench ISSN: 2008-2258